Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach.

Literature DB >> 24189852

Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach.

Giuseppe Boriani¹.

Abstract

Entities: Chemical

Mesh：

Substances：
Warfarin

Year: 2013 PMID： 24189852 DOI： 10.1378/chest.13-1285

Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. SAME-TT2R 2 score and vitamin K antagonist therapy.

Authors: Viroj Wiwanitkit
Journal: Intern Emerg Med Date: 2014-06-08 Impact factor: 3.397

2. Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Authors: David R Van Wagoner; Jonathan P Piccini; Christine M Albert; Mark E Anderson; Emelia J Benjamin; Bianca Brundel; Robert M Califf; Hugh Calkins; Peng-Sheng Chen; Nipavan Chiamvimonvat; Dawood Darbar; Lee L Eckhardt; Patrick T Ellinor; Derek V Exner; Richard I Fogel; Anne M Gillis; Jeff Healey; Stefan H Hohnloser; Hooman Kamel; David A Lathrop; Gregory Y H Lip; Reena Mehra; Sanjiv M Narayan; Jeffrey Olgin; Douglas Packer; Nicholas S Peters; Dan M Roden; Heather M Ross; Robert Sheldon; Xander H T Wehrens
Journal: Heart Rhythm Date: 2014-11-18 Impact factor: 6.343

Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach.

1. SAME-TT2R 2 score and vitamin K antagonist therapy.

2. Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Review 3. Potential use of NOACs in developing countries: pros and cons.

4. The Potential Role of Edoxaban in Stroke Prevention Guidelines.

5. Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality.

Review 6. New oral anticoagulants may be particularly useful for asian stroke patients.